U.S. regulators probe Peloton over treadmill injuries
Tweet
Share
E-mail
FILE PHOTO: A Peloton logo is seen on an exercise bike after the ringing of the opening bell for the company's IPO at the Nasdaq Market site in New York City, New York, U.S., September 26, 2019. REUTERS/Shannon Stapleton/File Photo
By Manas Mishra
(Reuters) -Peloton Interactive Inc said on Friday U.S. regulators were investigating the company, adding to the exercise bike maker's woes as it deals with a backlash over reports of accidents involving its treadmills.
The U.S. Department of Justice and the Department of Homeland Security have subpoenaed the company for documents and information over injuries from its exercise machines, the company said in a filing with the U.S. securities regulator https://bit.ly/38kFsf8.
Peloton recalled its Tread+ product in May, just weeks after saying there was "no reason" to stop using the exercise machine despite reports of the death of a child and multiple injuries.
Its public disclosures related to the reports are also under investigation by the U.S. Securities and Exchange Commission, Peloton said.
"Even with the treadmill 'fix' to prevent small children and pets from being injured, it is a high hurdle to get over when a child dies as a result of a product," said Walter Thompson, former president, American College of Sports Medicine.
Chief Executive Officer John Foley publicly apologized in May for Peloton's initial response to the accident reports, and the company also laid out steps to improve on safety.
Peloton said on Friday it had been named in several lawsuits associated with the recalls.
"We intend to cooperate fully with each of these investigations, and at this time, we are unable to predict the eventual scope, duration or outcome of the investigations," the company said.
The U.S. Consumer Product Safety Commission, which in April had warned about the dangers of the Tread+ treadmills, is already investigating the injuries.
Peloton said late on Thursday its near-term profitability would be affected due to a decision to slash the price of its exercise bike and higher commodity and marketing costs.
The company's shares were trading down 6.6% at $106.50 in afternoon trade.
(Reporting by Manas Mishra and Sanjana Shivdas in Bengaluru; Editing by Shounak Dasgupta and Vinay Dwivedi)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Enterprises raises dividend 5%, adds board member
- Calidi Biotherapeutics adds biopharma veteran Corsee Sanders to board
- XTEND wins $9M Middle East drone contract, adds two patents
Create E-mail Alert Related Categories
General News, Litigation, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
